Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

CASI Pharmaceuticals Inc Share Price

CASI

NAQ

$0.85

+$0.1

(13.36%)

Industry: Biotechnology Sector: Health Care

CASI Pharmaceuticals Inc Analyst Forecast

Overview Returns Financials Ratios News FAQs

CASI Pharmaceuticals Inc Share Price Chart

CASI Pharmaceuticals Inc Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$15.38M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

38.02K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

0.89

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$0.74 L

$3.09 H

$0.85

About CASI Pharmaceuticals Inc, Common Stock

CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in the People's Republic of China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation and as a palliative treatment for patients with multiple myeloma. The company's hematology/oncology assets in pipeline include CNCT19, an autologous CD19 CAR-T investigative product; BI-1206, an novel anti-Fc"RIIB antibody for the treatment of solid tumors and relapsed/refractory non-hodgkin lymphoma; CB-5339, a novel VCP/p97 inhibitor that focuses on valosin-containing protein (VCP)/p97 as a novel target in protein homeostasis, DNA damage response, and other cellular stress pathways for therapeutic use in the treatment of patients with various malignancies; CID-103, a human IgG1 anti-CD38 monoclonal antibody; and Thiotepa, a chemotherapeutic agent, which has various indications, including use as a conditioning treatment for use prior to certain allogeneic haemopoietic stem cell transplants. It has licensing agreements with Juventas Cell Therapy Ltd.; BioInvent International AB; Black Belt Therapeutics Limited; Cleave Therapeutics, Inc.; and Acrotech Biopharma L.L.C. to develop and commercialize its commercial product EVOMELA. CASI Pharmaceuticals, Inc. was incorporated in 1991 and is based in Beijing, the People's Republic of China. more

Industry: BiotechnologySector: Health Care

CASI Pharmaceuticals Inc Stock Returns

Time Frame	CASI	Sector	S&P500
1-Week Return	-19.07%	-1.08%	-1.38%
1-Month Return	-28.04%	-0.47%	-1.81%
3-Month Return	-43.94%	2.13%	1.38%
6-Month Return	-59.1%	17.04%	5.68%
1-Year Return	-71.1%	6.56%	11.74%
3-Year Return	-60.19%	16.78%	65.15%
5-Year Return	-97.36%	34.34%	73.68%
10-Year Return	-91.5%	137.88%	260.03%

Time Frame	CASI	Sector	S&P500
1-Week Return	-100.00%	-43.23%	-51.55%
1-Month Return	-98.17%	-5.57%	-19.93%
3-Month Return	-90.44%	8.92%	5.72%
6-Month Return	-83.68%	37.58%	11.85%
1-Year Return	-71.10%	6.56%	11.74%
3-Year Return	-26.44%	5.31%	18.20%
5-Year Return	-51.66%	6.08%	11.67%
10-Year Return	-21.85%	9.05%	13.67%

CASI Pharmaceuticals Inc Financials

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	15.14M	30.17M	43.11M	33.88M	28.54M	[{"date":"2020-12-31","value":35.12,"profit":true},{"date":"2021-12-31","value":69.98,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":78.59,"profit":true},{"date":"2024-12-31","value":66.2,"profit":true}]
Cost of Revenue	9.51M	12.56M	15.83M	13.83M	17.39M	[{"date":"2020-12-31","value":54.67,"profit":true},{"date":"2021-12-31","value":72.2,"profit":true},{"date":"2022-12-31","value":91.01,"profit":true},{"date":"2023-12-31","value":79.51,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit	5.63M	17.61M	27.28M	20.05M	11.15M	[{"date":"2020-12-31","value":20.65,"profit":true},{"date":"2021-12-31","value":64.56,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":73.5,"profit":true},{"date":"2024-12-31","value":40.86,"profit":true}]
Gross Margin	37.20%	58.38%	63.28%	59.19%	39.06%	[{"date":"2020-12-31","value":58.79,"profit":true},{"date":"2021-12-31","value":92.24,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":93.53,"profit":true},{"date":"2024-12-31","value":61.72,"profit":true}]

Operating Expenses	58.41M	59.13M	53.77M	45.13M	50.77M	[{"date":"2020-12-31","value":98.79,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":90.94,"profit":true},{"date":"2023-12-31","value":76.33,"profit":true},{"date":"2024-12-31","value":85.86,"profit":true}]
Operating Income	(52.78M)	(41.52M)	(26.49M)	(25.08M)	(39.62M)	[{"date":"2020-12-31","value":-5278100000,"profit":false},{"date":"2021-12-31","value":-4151600000,"profit":false},{"date":"2022-12-31","value":-2649100000,"profit":false},{"date":"2023-12-31","value":-2508000000,"profit":false},{"date":"2024-12-31","value":-3962100000,"profit":false}]
Total Non-Operating Income/Expense	6.14M	6.00M	(11.66M)	(598.00K)	1.22M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":97.7,"profit":true},{"date":"2022-12-31","value":-190.01,"profit":false},{"date":"2023-12-31","value":-9.75,"profit":false},{"date":"2024-12-31","value":19.88,"profit":true}]
Pre-Tax Income	(47.51M)	(35.84M)	(38.28M)	(26.29M)	(38.07M)	[{"date":"2020-12-31","value":-4751100000,"profit":false},{"date":"2021-12-31","value":-3584200000,"profit":false},{"date":"2022-12-31","value":-3827700000,"profit":false},{"date":"2023-12-31","value":-2629200000,"profit":false},{"date":"2024-12-31","value":-3806900000,"profit":false}]
Income Taxes	15.06M	1.93M	1.98M	(81.00K)	1.19M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":12.82,"profit":true},{"date":"2022-12-31","value":13.15,"profit":true},{"date":"2023-12-31","value":-0.54,"profit":false},{"date":"2024-12-31","value":7.9,"profit":true}]
Income After Taxes	(62.57M)	(37.77M)	(40.26M)	(26.21M)	(39.26M)	[{"date":"2020-12-31","value":-6256700000,"profit":false},{"date":"2021-12-31","value":-3777200000,"profit":false},{"date":"2022-12-31","value":-4025700000,"profit":false},{"date":"2023-12-31","value":-2621100000,"profit":false},{"date":"2024-12-31","value":-3925800000,"profit":false}]

Income From Continuous Operations	(47.51M)	(35.93M)	(40.26M)	(26.26M)	(39.26M)	[{"date":"2020-12-31","value":-4751100000,"profit":false},{"date":"2021-12-31","value":-3593000000,"profit":false},{"date":"2022-12-31","value":-4025700000,"profit":false},{"date":"2023-12-31","value":-2625900000,"profit":false},{"date":"2024-12-31","value":-3925800000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(48.29M)	(36.65M)	(41.01M)	(26.94M)	(39.26M)	[{"date":"2020-12-31","value":-4828700000,"profit":false},{"date":"2021-12-31","value":-3665400000,"profit":false},{"date":"2022-12-31","value":-4101400000,"profit":false},{"date":"2023-12-31","value":-2693800000,"profit":false},{"date":"2024-12-31","value":-3925800000,"profit":false}]

EPS (Diluted)	(4.20)	(2.70)	(2.98)	(2.02)	(2.56)	[{"date":"2020-12-31","value":-420,"profit":false},{"date":"2021-12-31","value":-270,"profit":false},{"date":"2022-12-31","value":-298,"profit":false},{"date":"2023-12-31","value":-202,"profit":false},{"date":"2024-12-31","value":-256,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	-	99.25%	42.89%	(21.41%)	(15.77%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":43.22,"profit":true},{"date":"2023-12-31","value":-21.57,"profit":false},{"date":"2024-12-31","value":-15.89,"profit":false}]
Cost of Revenue	-	32.07%	26.04%	(12.64%)	25.78%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":81.21,"profit":true},{"date":"2023-12-31","value":-39.41,"profit":false},{"date":"2024-12-31","value":80.38,"profit":true}]
Gross Profit	-	212.64%	54.90%	(26.50%)	(44.41%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":25.82,"profit":true},{"date":"2023-12-31","value":-12.46,"profit":false},{"date":"2024-12-31","value":-20.89,"profit":false}]
Gross Margin	-	56.91%	8.41%	(6.47%)	(34.01%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":14.77,"profit":true},{"date":"2023-12-31","value":-11.38,"profit":false},{"date":"2024-12-31","value":-59.76,"profit":false}]

Operating Expenses	-	1.22%	(9.06%)	(16.07%)	12.49%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":9.78,"profit":true},{"date":"2022-12-31","value":-72.55,"profit":false},{"date":"2023-12-31","value":-128.68,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income	-	(21.34%)	(36.19%)	(5.33%)	57.98%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-36.81,"profit":false},{"date":"2022-12-31","value":-62.42,"profit":false},{"date":"2023-12-31","value":-9.19,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	-	(2.30%)	(294.48%)	(94.87%)	(304.01%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]
Pre-Tax Income	-	(24.56%)	6.79%	(31.31%)	44.79%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-54.83,"profit":false},{"date":"2022-12-31","value":15.17,"profit":true},{"date":"2023-12-31","value":-69.9,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes	-	(87.18%)	2.59%	(104.09%)	(1567.90%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-3365.19,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-4017.91,"profit":false},{"date":"2024-12-31","value":-60520.99,"profit":false}]
Income After Taxes	-	(39.63%)	6.58%	(34.89%)	49.78%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-79.61,"profit":false},{"date":"2022-12-31","value":13.22,"profit":true},{"date":"2023-12-31","value":-70.09,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Income From Continuous Operations	-	(24.38%)	12.04%	(34.77%)	49.50%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-49.24,"profit":false},{"date":"2022-12-31","value":24.33,"profit":true},{"date":"2023-12-31","value":-70.24,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	(24.09%)	11.90%	(34.32%)	45.73%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-52.68,"profit":false},{"date":"2022-12-31","value":26.01,"profit":true},{"date":"2023-12-31","value":-75.04,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

EPS (Diluted)	-	(35.71%)	10.37%	(32.21%)	26.73%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-133.6,"profit":false},{"date":"2022-12-31","value":38.79,"profit":true},{"date":"2023-12-31","value":-120.51,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	7.79M	13.36M	6.24M	4.17M	3.08M	[{"date":"2024-09-30","value":58.35,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":46.72,"profit":true},{"date":"2025-06-30","value":31.26,"profit":true},{"date":"2025-09-30","value":23.02,"profit":true}]
Cost of Revenue	3.75M	10.13M	2.62M	2.12M	2.37M	[{"date":"2024-09-30","value":37.01,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":25.88,"profit":true},{"date":"2025-06-30","value":20.9,"profit":true},{"date":"2025-09-30","value":23.39,"profit":true}]
Gross Profit	4.04M	3.23M	3.62M	2.06M	706.00K	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":79.8,"profit":true},{"date":"2025-03-31","value":89.47,"profit":true},{"date":"2025-06-30","value":50.88,"profit":true},{"date":"2025-09-30","value":17.45,"profit":true}]
Gross Margin	51.91%	24.17%	58.00%	49.29%	22.96%	[{"date":"2024-09-30","value":89.5,"profit":true},{"date":"2024-12-31","value":41.67,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":84.99,"profit":true},{"date":"2025-09-30","value":39.59,"profit":true}]

Operating Expenses	12.51M	16.14M	14.00M	13.18M	11.38M	[{"date":"2024-09-30","value":77.49,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":86.72,"profit":true},{"date":"2025-06-30","value":81.67,"profit":true},{"date":"2025-09-30","value":70.52,"profit":true}]
Operating Income	(8.46M)	(12.91M)	(10.38M)	(11.13M)	(10.68M)	[{"date":"2024-09-30","value":-846400000,"profit":false},{"date":"2024-12-31","value":-1291400000,"profit":false},{"date":"2025-03-31","value":-1037900000,"profit":false},{"date":"2025-06-30","value":-1112500000,"profit":false},{"date":"2025-09-30","value":-1067700000,"profit":false}]
Total Non-Operating Income/Expense	1.12M	(1.61M)	(491.00K)	(275.00K)	(391.00K)	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":-143.33,"profit":false},{"date":"2025-03-31","value":-43.68,"profit":false},{"date":"2025-06-30","value":-24.47,"profit":false},{"date":"2025-09-30","value":-34.79,"profit":false}]
Pre-Tax Income	(7.28M)	(14.37M)	(10.75M)	(11.20M)	(10.88M)	[{"date":"2024-09-30","value":-727900000,"profit":false},{"date":"2024-12-31","value":-1437000000,"profit":false},{"date":"2025-03-31","value":-1075000000,"profit":false},{"date":"2025-06-30","value":-1120100000,"profit":false},{"date":"2025-09-30","value":-1088300000,"profit":false}]
Income Taxes	1.12M	73.00K	-	2.17M	-	[{"date":"2024-09-30","value":51.33,"profit":true},{"date":"2024-12-31","value":3.36,"profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Income After Taxes	(8.39M)	(14.44M)	-	(13.38M)	-	[{"date":"2024-09-30","value":-839500000,"profit":false},{"date":"2024-12-31","value":-1444300000,"profit":false},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":-1337500000,"profit":false},{"date":"2025-09-30","value":"-","profit":true}]

Income From Continuous Operations	(8.39M)	(14.37M)	(10.75M)	(13.38M)	(10.88M)	[{"date":"2024-09-30","value":-839500000,"profit":false},{"date":"2024-12-31","value":-1437000000,"profit":false},{"date":"2025-03-31","value":-1075000000,"profit":false},{"date":"2025-06-30","value":-1337500000,"profit":false},{"date":"2025-09-30","value":-1088300000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	(8.39M)	(14.37M)	(10.75M)	(13.38M)	(10.88M)	[{"date":"2024-09-30","value":-839500000,"profit":false},{"date":"2024-12-31","value":-1437000000,"profit":false},{"date":"2025-03-31","value":-1075000000,"profit":false},{"date":"2025-06-30","value":-1337500000,"profit":false},{"date":"2025-09-30","value":-1088300000,"profit":false}]

EPS (Diluted)	(0.55)	(0.75)	(0.69)	(0.86)	(0.68)	[{"date":"2024-09-30","value":-55,"profit":false},{"date":"2024-12-31","value":-75,"profit":false},{"date":"2025-03-31","value":-69,"profit":false},{"date":"2025-06-30","value":-86,"profit":false},{"date":"2025-09-30","value":-68,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	71.38%	(53.28%)	(33.09%)	(26.35%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-74.64,"profit":false},{"date":"2025-06-30","value":-46.36,"profit":false},{"date":"2025-09-30","value":-36.91,"profit":false}]
Cost of Revenue	-	170.22%	(74.12%)	(19.23%)	11.90%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-43.54,"profit":false},{"date":"2025-06-30","value":-11.3,"profit":false},{"date":"2025-09-30","value":6.99,"profit":true}]
Gross Profit	-	(20.20%)	12.11%	(43.13%)	(65.69%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-166.75,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-356.1,"profit":false},{"date":"2025-09-30","value":-542.36,"profit":false}]
Gross Margin	-	(53.44%)	139.96%	(15.01%)	(53.42%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-38.18,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-10.72,"profit":false},{"date":"2025-09-30","value":-38.17,"profit":false}]

Operating Expenses	-	29.04%	(13.28%)	(5.82%)	(13.65%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-45.73,"profit":false},{"date":"2025-06-30","value":-20.05,"profit":false},{"date":"2025-09-30","value":-47.01,"profit":false}]
Operating Income	-	52.58%	(19.63%)	7.19%	(4.03%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-37.34,"profit":false},{"date":"2025-06-30","value":13.67,"profit":true},{"date":"2025-09-30","value":-7.66,"profit":false}]
Total Non-Operating Income/Expense	-	(243.33%)	(69.52%)	(43.99%)	42.18%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-576.85,"profit":false},{"date":"2025-03-31","value":-164.82,"profit":false},{"date":"2025-06-30","value":-104.29,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Pre-Tax Income	-	97.42%	(25.19%)	4.20%	(2.84%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-25.86,"profit":false},{"date":"2025-06-30","value":4.31,"profit":true},{"date":"2025-09-30","value":-2.91,"profit":false}]
Income Taxes	-	(93.46%)	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Income After Taxes	-	72.04%	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Income From Continuous Operations	-	71.17%	(25.19%)	24.42%	(18.63%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-35.39,"profit":false},{"date":"2025-06-30","value":34.31,"profit":true},{"date":"2025-09-30","value":-26.18,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	-	71.17%	(25.19%)	24.42%	(18.63%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-35.39,"profit":false},{"date":"2025-06-30","value":34.31,"profit":true},{"date":"2025-09-30","value":-26.18,"profit":false}]

EPS (Diluted)	-	36.36%	(8.00%)	24.64%	(20.93%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-22,"profit":false},{"date":"2025-06-30","value":67.75,"profit":true},{"date":"2025-09-30","value":-57.56,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	74.03M	61.97M	73.42M	59.34M	39.58M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":83.71,"profit":true},{"date":"2022-12-31","value":99.19,"profit":true},{"date":"2023-12-31","value":80.17,"profit":true},{"date":"2024-12-31","value":53.46,"profit":true}]
Non-current Assets	53.71M	76.33M	22.81M	15.92M	13.90M	[{"date":"2020-12-31","value":70.37,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":29.89,"profit":true},{"date":"2023-12-31","value":20.86,"profit":true},{"date":"2024-12-31","value":18.21,"profit":true}]
Total Assets	127.73M	138.30M	96.23M	75.27M	53.67M	[{"date":"2020-12-31","value":92.36,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":69.58,"profit":true},{"date":"2023-12-31","value":54.42,"profit":true},{"date":"2024-12-31","value":38.81,"profit":true}]

Total Liabilities
Current Liabilities	7.98M	13.19M	17.00M	16.73M	36.45M	[{"date":"2020-12-31","value":21.88,"profit":true},{"date":"2021-12-31","value":36.17,"profit":true},{"date":"2022-12-31","value":46.65,"profit":true},{"date":"2023-12-31","value":45.88,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Liabilities	16.18M	17.15M	12.30M	34.38M	15.37M	[{"date":"2020-12-31","value":47.08,"profit":true},{"date":"2021-12-31","value":49.9,"profit":true},{"date":"2022-12-31","value":35.77,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":44.71,"profit":true}]
Total Liabilities	24.16M	30.34M	29.30M	51.10M	51.82M	[{"date":"2020-12-31","value":46.62,"profit":true},{"date":"2021-12-31","value":58.54,"profit":true},{"date":"2022-12-31","value":56.54,"profit":true},{"date":"2023-12-31","value":98.61,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	1.24M	1.40M	1.00K	1.00K	2.00K	[{"date":"2020-12-31","value":88.63,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":0.07,"profit":true},{"date":"2023-12-31","value":0.07,"profit":true},{"date":"2024-12-31","value":0.14,"profit":true}]
Retained Earnings	(570.50M)	(605.64M)	(637.16M)	(660.82M)	(700.08M)	[{"date":"2020-12-31","value":-57050100000,"profit":false},{"date":"2021-12-31","value":-60564300000,"profit":false},{"date":"2022-12-31","value":-63716000000,"profit":false},{"date":"2023-12-31","value":-66081700000,"profit":false},{"date":"2024-12-31","value":-70007500000,"profit":false}]
Other Stockholders' Equity	650.21M	686.79M	682.44M	686.18M	703.70M	[{"date":"2020-12-31","value":92.4,"profit":true},{"date":"2021-12-31","value":97.6,"profit":true},{"date":"2022-12-31","value":96.98,"profit":true},{"date":"2023-12-31","value":97.51,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	81.54M	84.50M	44.57M	24.16M	1.85M	[{"date":"2020-12-31","value":96.49,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":52.75,"profit":true},{"date":"2023-12-31","value":28.6,"profit":true},{"date":"2024-12-31","value":2.19,"profit":true}]

Total Liabilities & Shareholders Equity	105.70M	114.84M	73.88M	75.27M	53.67M	[{"date":"2020-12-31","value":92.04,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":64.33,"profit":true},{"date":"2023-12-31","value":65.54,"profit":true},{"date":"2024-12-31","value":46.74,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	-	(16.29%)	18.48%	(19.18%)	(33.31%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-88.12,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-103.75,"profit":false},{"date":"2024-12-31","value":-180.24,"profit":false}]
Non-current Assets	-	42.11%	(70.11%)	(30.19%)	(12.70%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-166.49,"profit":false},{"date":"2023-12-31","value":-71.69,"profit":false},{"date":"2024-12-31","value":-30.17,"profit":false}]
Total Assets	-	8.27%	(30.42%)	(21.79%)	(28.69%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-367.77,"profit":false},{"date":"2023-12-31","value":-263.43,"profit":false},{"date":"2024-12-31","value":-346.9,"profit":false}]

Total Liabilities
Current Liabilities	-	65.32%	28.96%	(1.64%)	117.94%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":55.39,"profit":true},{"date":"2022-12-31","value":24.56,"profit":true},{"date":"2023-12-31","value":-1.39,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Liabilities	-	5.98%	(28.31%)	179.56%	(55.29%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":3.33,"profit":true},{"date":"2022-12-31","value":-15.77,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-30.79,"profit":false}]
Total Liabilities	-	25.57%	(3.42%)	74.40%	1.41%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":34.37,"profit":true},{"date":"2022-12-31","value":-4.59,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":1.89,"profit":true}]

Total Shareholders' equity
Common Stock	-	12.82%	(99.93%)	-	100.00%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":12.82,"profit":true},{"date":"2022-12-31","value":-99.93,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	-	6.16%	5.20%	3.71%	5.94%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":84.48,"profit":true},{"date":"2023-12-31","value":60.28,"profit":true},{"date":"2024-12-31","value":96.44,"profit":true}]
Other Stockholders' Equity	-	5.63%	(0.63%)	0.55%	2.55%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-11.27,"profit":false},{"date":"2023-12-31","value":9.75,"profit":true},{"date":"2024-12-31","value":45.38,"profit":true}]
Total Shareholders' equity	-	3.63%	(47.25%)	(45.79%)	(92.34%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-1300.76,"profit":false},{"date":"2023-12-31","value":-1260.45,"profit":false},{"date":"2024-12-31","value":-2542,"profit":false}]

Total Liabilities & Shareholders Equity	-	8.65%	(35.67%)	1.88%	(28.69%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-412.52,"profit":false},{"date":"2023-12-31","value":21.79,"profit":true},{"date":"2024-12-31","value":-331.78,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	47.15M	39.58M	27.16M	18.16M	11.91M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":83.93,"profit":true},{"date":"2025-03-31","value":57.61,"profit":true},{"date":"2025-06-30","value":38.52,"profit":true},{"date":"2025-09-30","value":25.27,"profit":true}]
Non-current Assets	16.46M	13.90M	13.66M	13.04M	12.55M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":84.43,"profit":true},{"date":"2025-03-31","value":82.95,"profit":true},{"date":"2025-06-30","value":79.2,"profit":true},{"date":"2025-09-30","value":76.21,"profit":true}]
Total Assets	63.62M	53.67M	40.82M	31.20M	24.46M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":84.37,"profit":true},{"date":"2025-03-31","value":64.17,"profit":true},{"date":"2025-06-30","value":49.05,"profit":true},{"date":"2025-09-30","value":38.45,"profit":true}]

Total Liabilities
Current Liabilities	14.74M	36.45M	33.71M	37.74M	39.42M	[{"date":"2024-09-30","value":37.39,"profit":true},{"date":"2024-12-31","value":92.47,"profit":true},{"date":"2025-03-31","value":85.52,"profit":true},{"date":"2025-06-30","value":95.73,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Liabilities	35.03M	15.37M	15.18M	13.78M	13.63M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":43.88,"profit":true},{"date":"2025-03-31","value":43.33,"profit":true},{"date":"2025-06-30","value":39.32,"profit":true},{"date":"2025-09-30","value":38.92,"profit":true}]
Total Liabilities	49.77M	51.82M	48.89M	51.51M	53.05M	[{"date":"2024-09-30","value":93.81,"profit":true},{"date":"2024-12-31","value":97.68,"profit":true},{"date":"2025-03-31","value":92.15,"profit":true},{"date":"2025-06-30","value":97.09,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	2.00K	2.00K	2.00K	2.00K	2.00K	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	(685.71M)	(700.08M)	(710.83M)	(724.20M)	(735.09M)	[{"date":"2024-09-30","value":-68570500000,"profit":false},{"date":"2024-12-31","value":-70007500000,"profit":false},{"date":"2025-03-31","value":-71082500000,"profit":false},{"date":"2025-06-30","value":-72420000000,"profit":false},{"date":"2025-09-30","value":-73509000000,"profit":false}]
Other Stockholders' Equity	701.02M	703.70M	704.98M	706.13M	711.63M	[{"date":"2024-09-30","value":98.51,"profit":true},{"date":"2024-12-31","value":98.88,"profit":true},{"date":"2025-03-31","value":99.07,"profit":true},{"date":"2025-06-30","value":99.23,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	13.85M	1.85M	(8.07M)	(20.31M)	(28.59M)	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":13.37,"profit":true},{"date":"2025-03-31","value":-58.28,"profit":false},{"date":"2025-06-30","value":-146.67,"profit":false},{"date":"2025-09-30","value":-206.49,"profit":false}]

Total Liabilities & Shareholders Equity	63.62M	53.67M	40.82M	31.20M	24.46M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":84.37,"profit":true},{"date":"2025-03-31","value":64.17,"profit":true},{"date":"2025-06-30","value":49.05,"profit":true},{"date":"2025-09-30","value":38.45,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	-	(16.07%)	(31.36%)	(33.14%)	(34.40%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Non-current Assets	-	(15.57%)	(1.76%)	(4.52%)	(3.78%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Total Assets	-	(15.63%)	(23.95%)	(23.56%)	(21.60%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Total Liabilities
Current Liabilities	-	147.32%	(7.51%)	11.94%	4.46%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-5.1,"profit":false},{"date":"2025-06-30","value":8.1,"profit":true},{"date":"2025-09-30","value":3.03,"profit":true}]
Non-current Liabilities	-	(56.12%)	(1.26%)	(9.24%)	(1.03%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Total Liabilities	-	4.13%	(5.66%)	5.36%	2.99%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":76.98,"profit":true},{"date":"2025-03-31","value":-105.54,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":55.84,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Retained Earnings	-	2.10%	1.54%	1.88%	1.50%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":73.27,"profit":true},{"date":"2025-06-30","value":89.79,"profit":true},{"date":"2025-09-30","value":71.75,"profit":true}]
Other Stockholders' Equity	-	0.38%	0.18%	0.16%	0.78%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":49.03,"profit":true},{"date":"2025-03-31","value":23.38,"profit":true},{"date":"2025-06-30","value":20.87,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	-	(86.63%)	(535.98%)	151.67%	40.78%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-57.12,"profit":false},{"date":"2025-03-31","value":-353.38,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":26.89,"profit":true}]

Total Liabilities & Shareholders Equity	-	(15.63%)	(23.95%)	(23.56%)	(21.60%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	(25.89M)	(26.84M)	(21.09M)	(19.97M)	(29.22M)	[{"date":"2020-12-31","value":-2588600000,"profit":false},{"date":"2021-12-31","value":-2684200000,"profit":false},{"date":"2022-12-31","value":-2108800000,"profit":false},{"date":"2023-12-31","value":-1996700000,"profit":false},{"date":"2024-12-31","value":-2922400000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(20.72M)	(20.69M)	31.16M	(9.67M)	11.24M	[{"date":"2020-12-31","value":-66.49,"profit":false},{"date":"2021-12-31","value":-66.4,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-31.04,"profit":false},{"date":"2024-12-31","value":36.09,"profit":true}]

Financing Activities
Net Financing Cash Flow	47.15M	29.64M	(3.27M)	(907.00K)	15.43M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":62.86,"profit":true},{"date":"2022-12-31","value":-6.93,"profit":false},{"date":"2023-12-31","value":-1.92,"profit":false},{"date":"2024-12-31","value":32.73,"profit":true}]

Net Change in Cash	3.44M	(18.36M)	8.41M	(30.03M)	(3.62M)	[{"date":"2020-12-31","value":40.95,"profit":true},{"date":"2021-12-31","value":-218.36,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-357.15,"profit":false},{"date":"2024-12-31","value":-42.99,"profit":false}]

Free Cash Flow
Free Cash Flow	(45.21M)	(42.34M)	(26.70M)	(22.21M)	(29.46M)	[{"date":"2020-12-31","value":-4521300000,"profit":false},{"date":"2021-12-31","value":-4234200000,"profit":false},{"date":"2022-12-31","value":-2670000000,"profit":false},{"date":"2023-12-31","value":-2220800000,"profit":false},{"date":"2024-12-31","value":-2946400000,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	-	3.69%	(21.44%)	(5.32%)	46.36%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":7.97,"profit":true},{"date":"2022-12-31","value":-46.24,"profit":false},{"date":"2023-12-31","value":-11.47,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(0.14%)	(250.59%)	(131.04%)	(216.24%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	(37.14%)	(111.02%)	(72.24%)	(1801.65%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Net Change in Cash	-	(633.26%)	(145.80%)	(457.15%)	(87.96%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(6.35%)	(36.94%)	(16.82%)	32.67%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-19.43,"profit":false},{"date":"2022-12-31","value":-113.07,"profit":false},{"date":"2023-12-31","value":-51.49,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Net Change in Cash	7.00M	(3.07M)	(2.57M)	(4.16M)	(2.06M)	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":-43.82,"profit":false},{"date":"2025-03-31","value":-36.71,"profit":false},{"date":"2025-06-30","value":-59.35,"profit":false},{"date":"2025-09-30","value":-29.34,"profit":false}]

Free Cash Flow
Free Cash Flow	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Net Change in Cash	-	(143.82%)	(16.23%)	61.69%	(50.57%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-233.14,"profit":false},{"date":"2025-03-31","value":-26.3,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-81.97,"profit":false}]

Free Cash Flow
Free Cash Flow	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

CASI Pharmaceuticals Inc Ratios

CASI Pharmaceuticals Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	CASI
Cash Ratio	0.12
Current Ratio	0.30
Quick Ratio	0.24

CASI Pharmaceuticals Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	CASI
ROA (LTM)	-61.80%
ROE (LTM)	-1094.50%

CASI Pharmaceuticals Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	CASI
Debt Ratio Lower is generally better. Negative is bad.	2.17
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	-1.17

CASI Pharmaceuticals Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	CASI
Trailing PE	NM
Forward PE	NM
P/S (TTM)	0.43
P/B	11.21
EV/R	1.10
EV/Ebitda	0.07
PEG	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is CASI Pharmaceuticals Inc share price today?

CASI Pharmaceuticals Inc (CASI) share price today is $0.85

Can Indians buy CASI Pharmaceuticals Inc shares?

Yes, Indians can buy shares of CASI Pharmaceuticals Inc (CASI) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CASI stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of CASI Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of CASI Pharmaceuticals Inc (CASI) via the Vested app. You can start investing in CASI Pharmaceuticals Inc (CASI) with a minimum investment of $1.

How to invest in CASI Pharmaceuticals Inc shares from India?

You can invest in shares of CASI Pharmaceuticals Inc (CASI) via Vested in three simple steps:

Click on Sign Up or Invest in CASI stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in CASI Pharmaceuticals Inc shares

What is CASI Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of CASI Pharmaceuticals Inc (CASI) is $3.09. The 52-week low price of CASI Pharmaceuticals Inc (CASI) is $0.74.

What is CASI Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of CASI Pharmaceuticals Inc (CASI) is

What is CASI Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of CASI Pharmaceuticals Inc (CASI) is 11.21

What is CASI Pharmaceuticals Inc dividend yield?

The dividend yield of CASI Pharmaceuticals Inc (CASI) is 0.00%

What is the Market Cap of CASI Pharmaceuticals Inc?

The market capitalization of CASI Pharmaceuticals Inc (CASI) is $15.38M

What is CASI Pharmaceuticals Inc's stock symbol?

The stock symbol (or ticker) of CASI Pharmaceuticals Inc is CASI

How Can Investors Use CASI Pharmaceuticals Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of CASI Pharmaceuticals Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether CASI Pharmaceuticals Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from CASI Pharmaceuticals Inc shares for Indian investors?

When investing in CASI Pharmaceuticals Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the CASI Pharmaceuticals Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare CASI Pharmaceuticals Inc share price with other stocks in the same sector?

Rather than merely checking the share price of CASI Pharmaceuticals Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that CASI Pharmaceuticals Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

CASI Pharmaceuticals Inc Share Price

CASI Pharmaceuticals Inc Analyst Forecast

CASI Pharmaceuticals Inc Share Price Chart

CASI Pharmaceuticals Inc Key Stock Metrics

About CASI Pharmaceuticals Inc, Common Stock

CASI Pharmaceuticals Inc Stock Returns

CASI Pharmaceuticals Inc Financials

CASI Pharmaceuticals Inc Ratios

CASI Pharmaceuticals Inc Liquidity Ratios

CASI Pharmaceuticals Inc Asset Efficiency Ratios

CASI Pharmaceuticals Inc Liability Ratios

CASI Pharmaceuticals Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

CASI Pharmaceuticals Inc Share Price

CASI Pharmaceuticals Inc Analyst Forecast

CASI Pharmaceuticals Inc Share Price Chart

CASI Pharmaceuticals Inc Key Stock Metrics

About CASI Pharmaceuticals Inc, Common Stock

CASI Pharmaceuticals Inc Stock Returns

CASI Pharmaceuticals Inc Financials

CASI Pharmaceuticals Inc Ratios

CASI Pharmaceuticals Inc Liquidity Ratios

CASI Pharmaceuticals Inc Asset Efficiency Ratios

CASI Pharmaceuticals Inc Liability Ratios

CASI Pharmaceuticals Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²